Wyeth

Companies Wyeth

News Wyeth

• PolyTherics appoints Dr John Burt as Chief Business Officer

  PolyTherics Limited announced the appointment of Dr John Burt as Chief Business Officer. John has broad business and corporate development experience and was previously CEO of Thiakis, a company which he co-founded with Professor Steve Bloom of Imperial College in 2004 and sold to Wyeth in 2008. more

• Ablynx eligible for milestone payment as Pfizer initiates Phase I clinical trial with second Anti-TNF-alpha Nanobody

  Ablynx announced that it is now eligible for a milestone payment of $3 million as a result of the initiation by Pfizer of a new Phase I clinical study in healthy volunteers for a second Nanobody (PF-05230905) targeting tumour necrosis factor alpha (TNF-alpha). Pfizer's lead anti-TNF-alpha Nanobody more

• biocrea acquires CNS pipeline and PDE inhibitor platform from Biotie Therapies Corp. and announces corporate strategy

  biocrea GmbH announced further details about the newly incorporated company and its strategy going forward. biocrea acquires the CNS pipeline and phosphodiesterase enzyme (PDE) inhibitor platform from Biotie Therapies Corp. The new company will be based in Radebeul, Germany. Dr. Thomas Kronbach, Bi more

White papers Wyeth

• Wyeth 'learns and confirms' in India
  

  Aparna Singh (AS), Program Manager with Frost & Sullivan's Chemical Materials and Foods team caught up with Dr. Michael Kolb (Dr. MK) at Frost & Sullivan's Opportunities in Lifescience Molecules: Global Partnership Summit 2006. This annual summit was held at Goa (India) from 21st -23rd May, 2006. more

Publications Wyeth

• Association between reported venlafaxine use in early pregnancy and birth defects, national birth defects prevention study, 1997–2007

  Abstract BACKGROUND Few epidemiologic studies have investigated the use of venlafaxine (Effexor XR capsules, Product Monograph, Wyeth, Montreal, Canada), an antidepressant used to treat major depression and anxiety disorders in adults, during pregnancy. Our objective was to determine whether u more

• Maintaining a Cognitive Map in Darkness: The Need to Fuse Boundary Knowledge with Path Integration

  by Allen Cheung, David Ball, Michael Milford, Gordon Wyeth, Janet Wiles Spatial navigation requires the processing of complex, disparate and often ambiguous sensory data. The neurocomputations underpinning this vital ability remain poorly understood. Controversy remains as to whether mult more

• Rotavirus Vaccination: a Concise Review

  Abstract Live attenuated oral rotavirus vaccines were tested for proof‐of concept in the early 1980’s, the first vaccine (RotaShield®, Wyeth) was introduced in 1998 but subsequently withdrawn because of association with intussusception (IS), and the two currently licensed vaccine (Rotarix®, Glaxo more

Market studies Wyeth

• Colombia Pharmaceuticals and Healthcare Report Q4 2012

  BMI View: Pharmaceutical sales in Colombia are calculated to have reached a value of COP7,076bn (US$3.83bn) in 2011, of which patented drugs accounted for 67.1%., having posted an 8.6% year-onyear (y-o-y) local currency increase. While the operating environment remains challenging from the point of more

• World Influenza Vaccines Market 2011-2021

  Are you looking for influenza vaccine market data - answers to benefit your work? Our new report shows you revenue prospects for the manufacture and sale of influenza vaccines from 2009 to 2021. There, you will see commercial opportunities for influenza vaccines - original research, data and opini more

• World Biological Drugs Market 2011-2021

  Do you want to find market prospects for products and companies in the biological drugs industry? Our new report shows you biopharma revenue forecasts for 2011 to 2021. We provide original research, data and opinions to benefit your work now. What revenues will biopharmaceutical markets achieve fro more

Websites Wyeth